- Tytuł:
- Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial
- Autorzy:
- Źródło:
- In The Lancet Gastroenterology & Hepatology April 2019 4(4):269-277
- Czasopismo naukowe